NASDAQ$ZYXIQ

Zynex Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Reported highest quarterly revenue and positive net income for the eighteenth consecutive quarter.

Zynex reported an 81% increase in net revenue to $25.6 million and a net income of $1.8 million for the fourth quarter of 2020. Orders grew 117% compared to Q4 2019.

  • Net revenue increased by 81% compared to the fourth quarter of 2019.
  • Gross margins were 78% in the fourth quarter of 2020.
  • Net income was $1.8 million.
  • Orders grew 117% compared to the fourth quarter of 2019.

Headline financials

Total Revenue

$25.6M

Previous: $14.2M+80.8%
EPS (adj)

$0.05

Previous: $0.08-37.5%
Capital Expenditures

$226K

Previous: $28K+707.1%
Free Cash Flow

-$1.92M

Previous: $2.07M-192.9%
Net Income

$1.8M

Previous: $2.9M-37.9%
Operating Income

$0.00

Previous: $3.73M-100.0%
Gross Profit

$0.00

Previous: $11.4M-100.0%
Cash & Equivalents

$39.2M

Previous: $14M+180.0%
Total Assets

$72.2M

Previous: $28.3M+155.2%
Stock-Based Comp

$875K

Previous: $264K+231.4%

Revenue & EPS history

Zynex · Revenue · Quarterly

$25.6M

Q4 2020+80.8%vs Q4 2019
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Revenue by segment

Zynex · $49.9M total across 2 segments · Q3 2023

  • Supplies
    $33.1M
  • Devices
    $16.9M

Forward guidance

Full year 2021 revenue is estimated between $135.0 and $150.0 million with Adjusted EBITDA between $15.0 and $25.0 million. The revenue estimate for Q1 is approximately 51% to 61% above 2020 first quarter revenue of $15.2 million.

Tailwinds

  • Full year 2021 revenue is estimated between $135.0 and $150.0 million
  • Adjusted EBITDA between $15.0 and $25.0 million for full year 2021
  • Full year revenue estimate is approximately 68% to 87% above 2020 revenue of $80.1 million.
  • Revenue estimate for Q1 is approximately 51% to 61% above 2020 first quarter revenue of $15.2 million.

Headwinds

  • Adjusted EBITDA loss of between $0.5 and $1.5 million for Q1
  • First quarter revenue is historically affected by health insurance deductibles not being met in the beginning of the year.
  • Seasonality of deductibles affects Q1
  • Slower ramping of sales orders due to COVID-19 restrictions are factors which will produce a small loss in Q1.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports

Historical avg

+0.4%

Avg return

Earnings day

-1.8%

Avg return

5 days after

-6.5%

Avg return

30 days after

46%

29 / 63 earnings

Positive

+38.5%

Q3 2014

Best reaction

-51.6%

Q1 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2024-51.3%
Q3 2025+0.0%+0.0%-98.2%
Q2 2025+0.0%+0.0%+0.0%
Q1 2025-25.6%+0.0%+0.0%
Q3 2024+9.1%+0.0%+0.0%
Q2 2024-11.4%+0.0%+0.0%
Q1 2024+2.8%+0.0%+0.0%
Q4 2023-8.8%+0.0%+0.0%
Q3 2023+17.5%+0.0%+0.0%
Q2 2023+3.3%+0.0%+0.0%
Q1 2023+2.5%+0.0%+0.0%
Q4 2022+16.7%+0.0%+0.0%
Q3 2022+15.0%+0.0%+0.0%
Q2 2022+13.3%+0.0%+0.0%
Q1 2022-8.6%+0.0%+0.0%
Q4 2021-1.7%+0.0%+0.0%
Q3 2021+10.0%+0.0%+0.0%
Q2 2021-19.3%+0.0%+0.0%
Q1 2021-9.2%-12.0%-6.3%
Q4 2020-21.2%-22.4%-18.8%
Q3 2020-6.5%
Q2 2020-6.0%
Q1 2020-1.1%
Q4 2019+3.1%
Q3 2019-7.9%
Q2 2019+9.8%
Q1 2019+7.9%
Q4 2018-11.1%
Q3 2018+3.4%
Q2 2018-3.3%
Q1 2018+4.5%
Q4 2017-20.7%
Q3 2017+6.6%
Q2 2017+34.6%
Q1 2017-5.6%
Q4 2016+9.7%
Q3 2016+23.1%
Q2 2016+34.8%
Q1 2016+0.0%
Q4 2015+0.0%
Q3 2015-4.3%
Q2 2015-5.4%
Q4 2014+0.0%
Q1 2015+0.0%
Q3 2014+38.5%
Q2 2014+2.2%
Q1 2014-0.2%
Q4 2013-3.6%
Q3 2013+13.6%
Q2 2013+7.1%
Q1 2013+0.0%
Q4 2012+3.4%
Q3 2012+5.6%
Q2 2012-5.1%
Q1 2012-6.3%
Q4 2011+0.0%
Q3 2010+12.9%
Q3 2011+12.9%
Q2 2011+1.1%
Q1 2011-8.2%
Q4 2010+0.0%
Q2 2010+2.0%
Q1 2010-51.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro